Article in Journal of cellular biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.
Chemical communications (Cambridge, England) · 2022
Review
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors at 3 institutions in 2 countries.
Jéssica Martins de Moura ValadaresCampus Centro-Oeste Dona Lindú, Laboratório de Bioquímica Celular, Universidade Federal de São João Del-Rei, Divinópolis, Minas Gerais, Brazil.ORCID 0000-0002-9934-2793
Sumit O BajajDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.ORCID 0000-0003-4621-3055
Hongyan LiDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.ORCID 0000-0002-7073-5198
Hua-Yu L WangDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.ORCID 0000-0002-2727-9537
Simone Cavalcante SilvaDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.ORCID 0000-0002-0257-7546
Israel José Pereira GarciaCampus Centro-Oeste Dona Lindú, Laboratório de Bioquímica Celular, Universidade Federal de São João Del-Rei, Divinópolis, Minas Gerais, Brazil.ORCID 0000-0002-4972-6561
Duane Gischewiski PereiraCampus Centro-Oeste Dona Lindú, Laboratório de Bioquímica Celular, Universidade Federal de São João Del-Rei, Divinópolis, Minas Gerais, Brazil.ORCID 0000-0001-8353-761X
Pedro AzalimInstituto de Ciências Biomédicas, Laboratório de Farmacologia Bioquímica e Molecular, Universidade Federal do Rio de Janeiro, Rio de Janeiro, State of Rio de Janeiro, Brazil.ORCID 0000-0003-3272-4321
Luis Eduardo Menezes QuintasInstituto de Ciências Biomédicas, Laboratório de Farmacologia Bioquímica e Molecular, Universidade Federal do Rio de Janeiro, Rio de Janeiro, State of Rio de Janeiro, Brazil.ORCID 0000-0002-0767-1240
François NoëlInstituto de Ciências Biomédicas, Laboratório de Farmacologia Bioquímica e Molecular, Universidade Federal do Rio de Janeiro, Rio de Janeiro, State of Rio de Janeiro, Brazil.ORCID 0000-0001-6813-1347
Vanessa Faria CortesCampus Centro-Oeste Dona Lindú, Laboratório de Bioquímica Celular, Universidade Federal de São João Del-Rei, Divinópolis, Minas Gerais, Brazil.ORCID 0000-0002-6464-7634
George Augustine O'DohertyDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.ORCID 0000-0002-1699-2249
Leandro Augusto BarbosaCampus Centro-Oeste Dona Lindú, Laboratório de Bioquímica Celular, Universidade Federal de São João Del-Rei, Divinópolis, Minas Gerais, Brazil.ORCID 0000-0002-4631-0130
Federal University of São João del-Rei · BRNortheastern University · USUniversidade Federal do Rio de Janeiro · BR
Funding
Apramycin scaffold exploration using novel glycochemistry and SAR studies to enhance activity against Acinetobacter baumannii and other multidrug-resistant Gram-negative pathogensR21AI142040 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KIRBY, JAMES E, O'DOHERTY, GEORGE A · 2019 to 2020
$476k
Fusidic acid derivatization to enhance entry into Gram-negative pathogensR21AI146485 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KIRBY, JAMES E, O'DOHERTY, GEORGE A · 2019 to 2020
$475k
Targeted modification of the apramycin 2-deoxystreptamine ring to block aminoglycoside modifying enzyme-based inactivation and enhance potency against multidrug-resistant Gram-negative pathogensR03AI144196 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KIRBY, JAMES E, O'DOHERTY, GEORGE A · 2019 to 2020
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Cytotoxic effect of carbohydrate derivatives of digitoxigenin involves modulation of plasma membrane Ca · full record | OpenQuestion